£50 blood test could predict prostate cancer drug response
Researchers have developed a blood test that could better tailor the treatment of patients with prostate cancer.
Read More
Tag: Annals of Oncology
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
